IMCD (OTC:IMCDY) Upgraded to “Equal Weight” at Barclays

Barclays upgraded shares of IMCD (OTC:IMCDYGet Rating) from an underweight rating to an equal weight rating in a research note released on Monday, The Fly reports.

IMCD Stock Up 0.2 %

Shares of IMCDY stock opened at $75.78 on Monday. IMCD has a 52-week low of $53.55 and a 52-week high of $87.35. The firm’s 50 day moving average price is $77.76 and its two-hundred day moving average price is $77.03.

IMCD Company Profile

(Get Rating)

IMCD N.V. distributes, markets, and sells specialty chemicals and ingredients in the Netherlands, rest of Europe, the Middle East, Africa, North America, South America, and the Asia-Pacific. The company offers enzymes, surfactants, biocides, chelates, rheology modifiers, solubilisers, silicones, solvents, and functional additives; active pharmaceutical, agrochemicals, biopharma, excipients and formulation, nutraceuticals, and regulated synthesis; actives, UV sunscreens, rheology modifiers, thickeners, emulsifiers, emollients, elastomers, humectants, waxes, film formers, functional powders, hair styling polymers, hair conditioners, solvents, solubilizers, pigments, pearls, colorants, opacifiers, pearlisers, preservatives, antioxidants, additives, fragrances, and essential oils; and resins and binders, additives, functional fillers, and specialty solvents.

Featured Stories

The Fly logo

Receive News & Ratings for IMCD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IMCD and related companies with's FREE daily email newsletter.